WHO raises alarm over Fake Diabetes Drugs Circulating Worldwide

By Admin

The World Health Organisation (WHO) has cautioned the public concerning the circulation of fake diabetes drugs that have been on the market since 2022, impacting every part of the globe.

Citypost reports that the health organization, in a declaration, specifically mentioned issues with these fake drugs in the United Kingdom, the United States, and Brazil starting in October 2023.

According to the WHO, the issue involves Ozempic, a drug that includes the active ingredient semaglutide, which is also sanctioned in the EU for treating type 2 diabetes.